Literature DB >> 11249181

Degenerative lumbar stenosis: the neurosurgical perspective.

J M Sheehan1, C I Shaffrey, J A Jane.   

Abstract

Degenerative lumbar stenosis is a complex entity caused by predictable patterns of degenerative pathoanatomy. Patients with spinal stenosis are treated by orthopaedic surgeons and neurosurgeons, who often have slightly different ideas regarding treatment strategies. However, data exist to support several recommendations, regarding fusion with or without instrumentation, surgical versus conservative treatment, and limitation of procedures to symptomatic levels. In the current study, the typical patterns of degenerative disease and surgical treatment and a view of the neurosurgical perspective of the treatment of patients with lumbar stenosis are presented.

Entities:  

Mesh:

Year:  2001        PMID: 11249181

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Progression of lumbar spinal stenosis is influenced by polymorphism of thrombospondin 2 gene in the Korean population.

Authors:  Seung-Jae Hyun; Borae G Park; Seung-Chul Rhim; Jun-Won Jang; Sang-Ryong Jeon; Sung-Woo Roh
Journal:  Eur Spine J       Date:  2013-06-27       Impact factor: 3.134

2.  Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis.

Authors:  N Noponen-Hietala; E Kyllönen; M Männikkö; E Ilkko; J Karppinen; J Ott; L Ala-Kokko
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

3.  Minimally Invasive Transforaminal Lumbar Interbody Fusion at L5-S1 through a Unilateral Approach: Technical Feasibility and Outcomes.

Authors:  Won-Suh Choi; Jin-Sung Kim; Kyeong-Sik Ryu; Jung-Woo Hur; Ji-Hoon Seong
Journal:  Biomed Res Int       Date:  2016-06-28       Impact factor: 3.411

4.  The identification of novel gene mutations for degenerative lumbar spinal stenosis using whole-exome sequencing in a Chinese cohort.

Authors:  Xin Jiang; Dong Chen
Journal:  BMC Med Genomics       Date:  2021-05-21       Impact factor: 3.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.